PUMD Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume600.00
Average Volume (3M)0.00
Market Cap
$1.86K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,605,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PUMD FAQ
What was ProUroCare Medical Inc.’s price range in the past 12 months?
ProUroCare Medical Inc. lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is ProUroCare Medical Inc.’s market cap?
ProUroCare Medical Inc.’s market cap is $1.86K.
When is ProUroCare Medical Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ProUroCare Medical Inc.’s earnings last quarter?
Currently, no data Available
Is ProUroCare Medical Inc. overvalued?
According to Wall Street analysts ProUroCare Medical Inc.’s price is currently Overvalued.
Does ProUroCare Medical Inc. pay dividends?
ProUroCare Medical Inc. does not currently pay dividends.
What is ProUroCare Medical Inc.’s EPS estimate?
ProUroCare Medical Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProUroCare Medical Inc. have?
ProUroCare Medical Inc. has 18,605,000 shares outstanding.
What happened to ProUroCare Medical Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ProUroCare Medical Inc.?
Currently, no hedge funds are holding shares in PUMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ProUroCare Medical Inc.
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Technical Analysis
Enveric Biosciences
―
Catheter Precision
―
Bluejay Diagnostics
―
CDT Equity
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---